COc1ccc(C2CC(=O)N(Cc3ccccc3)c3c2c(C)nn3-c2nc(C)cc(C)n2)c(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?